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Accurate prediction of risk-states in Serious Mental Illnesses (SMIs) is critical for reducing their massive societal 
burden. Risk-state assessments are notably inaccurate. Recent innovations, including widely available and 
inexpensive mobile technologies for ambulatory “biobehavioral” data, can reshape risk assessment. To help 
understand and accelerate clinician involvement, we surveyed 90 multi-disciplinary clinicians serving SMI 
populations in various settings to evaluate how risk assessment is conducted and can improve. Clinicians reported 
considerable variability in conducting risk assessment, and few clinicians explicated their procedures beyond tying it 
to broader mental status examinations or interviews. Very few clinicians endorsed using currently-available 
standardized risk measures, and most reported low confidence in their utility. Clinicians also reported spending 
approximately half the time conducting individual risk assessments than optimally needed. When asked about 
improvement, virtually no clinicians acknowledged biobehavioral, objective technologies, or ambulatory recording. 
Overall, clinicians seemed unaware of meaningful ways to improve risk assessment.  
 















Running head: CLINICIAN PERSPECTIVE ON RISK ASSESSMENT  
3 
 
The state of risk assessment for Serious Mental Illness 
Serious mental illnesses (SMIs) have a massive impact on society (Insel, 2008; Kessler et al., 2009; Stuart & 
Weinrich, 1998). Much of this impact stems from treating psychiatric emergencies involving unfortunate events 
such as suicidality, self-harm, homicidality/harm to others, functional decompensation, relapse from substance use, 
and medication side-effects (Stuart & Weinrich, 1998; Wu et al., 2005). Thus, accurate and efficient assessment of 
these various psychiatric “risk states” are critical for reducing the burden of psychiatric disease. At present, a host of 
“empirically-supported” psychiatric risk assessments exist (Wand, 2012). While these assessments vary in scope and 
approach, current evidence raises serious questions about their accuracy for predicting psychiatric events at the 
individual level for suicidality (Bernert, Hom, & Roberts, 2014; Chan et al., 2016; H. D. Nelson et al., 2017), 
homicidality (Campbell, French, & Gendreau, 2009; Yang, Wong, & Coid, 2010), decompensation (Joseph et al., 
2017; O’Hagan, Cornelius, Young, & Taylor, 2017), treatment compliance (Rubin, Dolev, & Zilcha-Mano, 2016; 
Velligan et al., 2009), and psychosis (Schmidt et al., 2017). Consider, for example, meta-analysis suggesting that 
clinicians are no better than chance for predicting suicide (e.g., Grove et al., 2000), and that the “validated” 
measures for predicting suicide confer only a five to ten percent advantage over this (e.g., Grove et al., 2000, Chan 
et al., 2016). Similarly, Large and colleagues (Large et al., 2019) reported that current risk assessment tools are 
inaccurate for predicting suicide behavior even in “high” risk patients; with about half of all suicides occurring in 
low-risk groups and 95% of high-risk patients not attempting suicide. In short, our ability to accurately predict 
behavior in an individual over a relatively brief temporal epoch with acceptably low false positive rates is currently 
unacceptable.  
 To complement traditional risk assessment approaches, there have been efforts to advance risk prediction 
using objective data analysis such as  using genetic, neurobiological, physiological, and ambulatory tracking data 
(Cohen & Elvevåg, 2014; Nelson, McGorry, Wichers, Wigman, & Hartmann, 2017; Seidman et al., 2016; Vassos et 
al., 2017). Although these “nontraditional” efforts have existed for decades, three major advances are helping 
reshape how risk assessments are conducted. The first major advance is that “biobehavioral” measures, evaluating 
specific channels of objectively-defined behavior (e.g., electro-encephalography (EEG), eye-tracking, facial and 
speech analysis) have become relatively inexpensive. Second, many of these technologies yield continuous data 
streams that can be collected unobtrusively while a patient navigates their daily routine – thus extending assessment 
well beyond the confines of the traditional clinical setting (Ben-Zeev et al., 2012; Ben-Zeev, Davis, Kaiser, Krzsos, 
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& Drake, 2013). These include a variety of passive monitoring, psychophysiology, natural language processing, 
social media, and self-report recording approaches. Third, within the last decade methodological and statistical 
procedures have become more available for analyzing these “big data” streams (Torous & Baker, 2016). 
Collectively, these advances hold the potential to provide low-cost and time-efficient assessment procedures that are 
translatable to a wide array of risk-states. To date, a number of projects have been proposed and evaluated to 
improve risk assessment of suicide/self-harm (Bridge, Horowitz, & Campo, 2017; Gaynes et al., 2004), 
homicide/harm-to-others (Vitacco, Tabernik, Zavodny, Bailey, & Waggoner, 2016), psychosis onset and 
decompensation (Ben-Zeev et al., 2013; Cannon et al., 2016; Carrión et al., 2016), cognitive decline (Harrison et al., 
2017) and mania (Hafeman et al., 2017). The potential of these efforts has garnered support from major 
organizations (Boudreaux & Horowitz, 2014; Cannon et al., 2008a, 2016; Heeringa et al., 2013; Hoffmire et al., 
2016a; Insel, 2008; Schoenbaum et al., 2014a). With respect to suicide, machine-learning based algorithms using 
medical record (e.g., Walsh, 2017) and various biobehavioral technologies (e.g., Pestian et al., 2017) have been 
developed with impressive accuracy rates (e.g., exceeding 85%). These advances have, in some cases, been 
clinically implemented (e.g., the STARRS program; Kessler et al., 2015). While advances in psychiatric risk 
prediction are still in their infancy, their promise for a broad range of applications is quite high – particularly given 
they can potentially integrate genetic, neurodevelopmental, family history, social media and varying biobehavioral 
data streams together.  
As yet, it is unclear whether these nontraditional approaches, which are not primarily based on clinical 
interview and clinician judgement, have been acknowledged and received by relevant stakeholders, in particular, 
clinicians whose practice involves various types of risk assessment (see Cohen et al., 2019 and Holmlund et al., 
2019 for additional discussion). As noted by the American Medical Informatics Association, it often takes over a 
decade for innovation to be implemented by practitioners in health-related fields, and this implementation tends to 
occur only in pockets (Beal, 2012; Kessler & Glasgow, 2011). To address this, many have advocated that 
stakeholders need to be involved meaningfully and continuously from the outset of the innovation process (Peek et 
al., 2014). The potential pitfalls of not involving these stakeholders from inception include perceived lack of 
relevance as well as “laboratory” solutions that may not be suited for real-world application (Rothwell, 2005). The 
purpose of this paper is to survey a multidisciplinary network of clinicians about current and future risk assessment. 
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This information could prove vital for developing a “next generation” of risk assessment procedures and for 
facilitating participation of practicing clinicians in this process. We aimed to answer four questions:  
1. What types of risk are clinicians concerned about in SMI? 
2. How is risk currently assessed? 
3. How often, and for how long, is risk assessment conducted? 
4. How can risk assessment be improved, and what role can technology play in this? 
 
The current study was approved by the Institutional Review Board of the university of the study’s lead investigator. 
We declare no conflict of interest.  All authors certify their responsibility for this manuscript. 
 
Survey Methods: 
Invitations to participate in the present survey were sent to clinicians providing services to individuals with SMI. 
These clinicians include representatives from psychiatric, psychological, counseling, social work, and nursing 
disciplines within the state of Louisiana via professional listservs associated with these disciplines. The survey was 
anonymous and approved by relevant institutional research boards. Questions in the survey tapped information 
regarding risk assessment in SMI using a mix of multiple-choice, Likert-style ratings, and open-ended text 
responses. Approximately 90 clinicians began the survey and 70 completed it. Average completion time for the 
latter group was 36 minutes (standard deviation [SD] = 3.11 minutes). The mean age of clinicians was 45.36 years 
(SD = 14.59; range 21 to 73). Information regarding the employment settings and training is provided in Table 1. 
 
[Insert Table 1 about here] 
 
What types of risk are clinicians concerned about in SMI? 
 Clinicians were presented with seven different types of risk and asked whether these reflected primary 
concerns for them in their practice. Nearly all indicated that risk of harming self (88%), treatment noncompliance 
(77%), and psychosis (74%) were primary concerns in their practice. Risk of harming others (67%) and 
decompensation (65%) were also listed as common primary concerns. Medication side effects were endorsed by 
about half of clinicians (52%) and risk of litigation was a primary concern for nearly one-quarter of the sample 
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(22%). These findings are consistent with extant literature in that harm to self and others is a pervasive concern in 
treatment of SMI patients. The relatively low endorsement of litigation as a primary concern was surprising given 
other studies (e.g., 75% of psychiatrists expressed concern; Brodsky, 1988; Kennedy & Gill, 1997; Passmore & 
Leung, 2002; Wilbert & Fulero, 1988).  
 
How is risk currently assessed? 
 Clinicians were asked about risk assessment procedures they employed for the various risk types they 
indicated in the prior section. First, they indicated what “format” best typified their assessment procedures (i.e. 
formal and informal mental status exams, structured and unstructured clinical interviews, and standardized clinical 
measures). Following this, they rated their confidence in the aforementioned formats. Finally, they described the 
assessment procedure they used via text responses. Table 2 contains these data. For all types of risk, mental status 
exams (i.e. formal and informal) and structured clinical interviews were endorsed as the most common formats used, 
collectively accounting for over 80% of responses. Conversely, unstructured clinical interviews and standardized 
clinical measures were not frequently used. Both structured and unstructured clinical interviews, but not mental 
status exams, engendered the greatest confidence for clinicians, with the former accounting for almost two thirds of 
responses. Standardized clinical measures were not often selected, with an average endorsement of less than 5%. 
When clinicians were asked to describe the assessment procedures they used, only eight clinicians responded to this 
and only four of these responses involved measures or procedures with published psychometric data. The others 
were nonspecific (e.g., “we refer to outside sources”, “my version of the mini-mental status exam”). In sum, there 
was remarkable divergence between clinician’s actual and optimal risk assessment procedures, and little qualitative 
explanation of their actual procedures used. Clinicians appeared to rarely use, and to have little confidence in, 
standardized measures.  
 
[Insert Table 2 about here] 
 
How often, and for how long, are risk assessments conducted?  
 Clinicians were asked questions about the duration of risk assessment. First, they were asked about the 
average time demands for them to conduct a risk assessment. They reported that, on average, 13.33 minutes was 
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spent assessing risk across the various domains. They also indicated that an optimal assessment should take nearly 
twice this time (mean = 23.99 minutes) and that their clients generally could tolerate an assessment somewhere in 
between (mean = 18.09 minutes). There was considerable variability in responses for each of these, with standard 
deviations approaching or exceeding each of these values (i.e., 15.00, 22.45 and 22.71 respectively). In sum, the 
actual time spent conducting risk assessment was far less than what would be spent conducting an optimal 
assessment, and there was considerable variability across clinicians.  
Clinicians were next asked about the actual and optimal frequency of their risk assessments (Table 3). 
There was considerable variability across risk domains, nonetheless, several trends emerged. Overall, the 
frequencies of actual and optimal risk assessments were fairly similar. Averaged across risk domains, optimal 
frequency of at least once per day was endorsed by 59% of clinicians, which was very close to the 57% reported for 
actual frequency. Across individual domains however, there were disparities between optimal and actual frequencies 
reported. The largest discrepancy was observed for self-harm, with 73% of clinicians indicating assessments should 
occur at least daily, whereas only 56% of clinicians indicating that daily assessments were actually conducted. 
Importantly, approximately 18% of clinicians reported actually assessing risk in intervals greater than a month, 
though only 5% of clinicians reported that this was optimal.  
 
[Insert Table 3 about here] 
 
Comparing responses as a function of inpatient versus outpatient treatment settings, there were some 
important similarities. In terms of the optimal frequency of self and other-harm assessment, approximately three 
quarters of clinicians from both settings indicated at least daily assessment was ideal. For other types of risk, the 
results varied between settings. Approximately two-thirds or more of clinicians from inpatient/Intensive OutPatient 
(IOP) settings recommended at least daily assessment for psychosis, medication side effects, and treatment 
noncompliance which was much higher than reported in the outpatient setting (differences of 14%, 36%, and 31% 
respectively). With respect to frequency of assessment, there was at least a 20% discrepancy in daily assessments 
between inpatient/IOP and outpatient settings for self-harm (67% versus 44% respectively), decompensation (65% 
versus 45% respectively), medication side effect (71% versus 25% respectively), and treatment noncompliance 
(64% versus 35% respectively). Hence, daily assessment was recommended and practiced by most clinicians for the 
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inpatient/IOP setting. Daily assessment of self-harm was recommended by most clinicians for the outpatient setting 
as well, though this was far below what was actually practiced. 
 
How can risk assessment be improved, and what role can technology play in this? 
 Clinicians were next asked how risk assessment can be improved. First, they provided Likert-style 
responses to a list of potential concerns using a scale from 1 (not at all concern) to 5 (extreme concern). These 
concerns covered a range of items related to accuracy, resources needed to conduct the assessment and share the 
results, and practical issues involving accessing and sharing results. The results are included in Table 6. Overall, the 
average responses fell somewhere between 2.12 (a little) and 3.57 (somewhat to very much). The most notable 
concerns were expressed in response to accuracy of assessments and getting results more quickly. Fewer concerns 
involved being able to track patients and access their results remotely. Comparing clinicians from inpatient versus 
outpatient settings, there were two notable differences in ratings (i.e., .50 item difference): getting results more 
quickly (3.37 versus 2.75 respectively) and being able to access results remotely (2.87 versus 2.35 respectively).  
 
[Insert Table 4 about here] 
 
        Clinicians next completed open-ended questions regarding concerns they had and how risk assessment 
could be improved. These question focused on risk assessment generally as opposed to specific types of risk 
assessment. The concerns were varied and centered around six themes. The most frequently noted concerns involved 
a lack of accuracy of risk assessment (noted by 23% of clinicians) and problems in alerting and sharing of critical 
risk assessment information (noted by 26% of clinicians). Other important themes involved inadequate time in 
session to conduct risk assessments (noted by 14% of clinicians), frequency of risk assessments (noted by 12% of 
clinicians), technical issues (e.g., slow computers/medical record access; noted by 9% of clinicians), and lack of 
uniformity between clinicians at the same organization (shared by 9% of clinicians). Of the responses, only one 
specifically mentioned the use of technology or methodologies to improve accuracy and efficiency. When asked 
about new tools or procedures for tracking risk status that might be helpful for patients and staff, 67% directly 
responded that they were not aware of any solutions, and an additional 27% failed to meaningfully include any 
mention of technology or innovation in their response. Technology-based solutions were present in only 14% of 
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 Technological and methodological advances hold the potential to greatly improve the accuracy and 
efficiency of risk assessment for a variety of clinical events. However, it is unclear whether clinicians, a primary 
stakeholder, are aware of these potential advances. The present study evaluated current and future risk assessment 
practices in a multi-disciplinary sample of clinicians recruited from diverse settings. As in prior studies, risk 
assessment was judged to be an important part of practice involving patients with a broad range of SMIs. There was 
considerable variability in how clinicians conducted risk assessment, and few of the clinicians explicated their 
assessment procedures beyond tying it to a broader mental status examination or interview. In fact, few clinicians 
endorsed using standardized risk assessment instruments, and many reported low confidence in their clinical utility. 
That being said, clinicians were not using the risk assessment procedures that they reportedly were most confident 
in. The reasons for this are unclear, but may reflect time demands, as clinicians reported spending approximately 
half the time conducting individual risk assessments that would be needed for optimal assessments. Importantly, it 
seems unlikely that increased time would dramatically improve risk prediction accuracy, except perhaps indirectly 
through improved rapport, increased information, reduced clinician stress and burden and improved documentation. 
When asked about improving risk assessment, virtually no clinicians acknowledged biobehavioral or objective 
technologies, pattern recognition, or ambulatory recording. A few mentioned potentially using technology to help 
connect clinicians and improve communication, though clinicians largely seemed to be unaware or perhaps 
pessimistic about the potential for risk assessment to improve.    
The present findings should be evaluated in light of several limitations. First, our sample was not 
necessarily representative of most clinicians in the world. Second, aspects of this survey were qualitative in nature. 
While potentially providing rich responses, characterizing null findings are particularly challenging.  Nonetheless, 
there are important implications for the future. Despite considerable attention in academic, private-sector and even 
governmental agencies, clinicians in the present sample seemed to be generally unaware or unconvinced that 
technology can play a significant role in improving the practice of risk assessment. Advances to risk assessment 
systems, by incorporating pattern recognition analytic techniques, electronic medical records, and alert systems has 
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been developed and, to varying degrees, adopted and implemented by large agencies (Hoffmire et al., 2016; Kessler 
et al., 2013; Schoenbaum et al., 2014), and similar algorithms are being developed for other types of risk (Cannon et 
al., 2008b, 2016). Despite these sorts of advances, major stakeholders appear to be largely unaware of these efforts. 
This presents an obvious problem in terms of implementation, as translating technological and methodological 
advances into clinical practice will require the attention and participation of clinicians. Increased outreach to and 
involvement from clinicians is most certainly warranted given that these assessments are primarily being developed 
to serve them and the patients under their care. 
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Table 1. Descriptive data for service professionals (n = 70) 
 
Primary Employment setting1 % 
     Emergency Room 17 
     Inpatient Treatment Facility 41 
     Intensive Outpatient Facility 6 
     Forensic Facility 3 
     Outpatient Clinic 45 
     Other 19 
Primary Training1  
     Medicine 22 
     Psychology 19 
     Social Work 16 
     Counseling 17 
     Nursing 17 
     Other 9 
1. Response options were mutually exclusive (i.e., only one response per participant) 
 





Table 2. Format of risk assessments conducted by clinicians: primary format used versus the format engendering greatest confidence.   
 













Risk of harming self Primary Format Used 1 
29% 30% 25% 13% 3% 
 Greatest Confidence 1  
23% 8% 35% 31% 4% 
Risk of harming others  Primary Format Used 1 
29% 30% 26% 12% 3% 
 Greatest Confidence 1  
23% 8% 33% 33% 5% 
Psychosis  Primary Format Used 1 
30% 33% 26% 9% 1% 
 Greatest Confidence 1  
20% 13% 35% 26% 4% 
Functional Decompensation  Primary Format Used 1 
30% 27% 27% 6% 5% 
 Greatest Confidence 1  
15% 8% 40% 28% 3% 
Medication side effects Primary Format Used 1 
23% 28% 28% 13% 8% 
 Greatest Confidence 1  
11% 15% 41% 26% 7% 
Treatment noncompliance Primary Format Used 1 
19% 30% 31% 5% 8% 
 Greatest Confidence 1  
10% 10% 35% 31% 2% 
Litigation Primary Format Used 1 
14% 29% 33% 14% 5% 
 Greatest Confidence 1  
22% 11% 0% 56% 0% 























Risk of harming self Optimal assessment frequency1 45% 28% 5% 10% 9% 2% 
 Actual assessment frequency1 28% 28% 2% 19% 7% 5% 
Risk of harming others  Optimal assessment frequency1 53% 23% 8% 5% 5% 5% 
 Actual assessment frequency1 41% 31% 3% 10% 3% 0% 
Psychosis  Optimal assessment frequency1 29% 31% 6% 13% 10% 8% 
 Actual assessment frequency1 28% 32% 4% 9% 4% 11% 
Functional Decompensation  Optimal assessment frequency1 17% 32% 10% 12% 15% 7% 
 Actual assessment frequency1 20% 35% 5% 8% 8% 5% 
Medication side effects Optimal assessment frequency1 19% 32% 0% 19% 13% 3% 
 Actual assessment frequency1 23% 23% 0% 17% 7% 7% 
Treatment noncompliance Optimal assessment frequency1 20% 24% 6% 22% 6% 16% 
 Actual assessment frequency1 21% 29% 4% 19% 4% 4% 
Litigation Optimal assessment frequency1 0% 0% 0% 0% 0% 0% 
 Actual assessment frequency1 0% 22% 11% 22% 0% 22% 
1. Response options were mutually exclusive (i.e., only one response per participant) 
 
 










Decreasing the amount of time it takes for an assessment 2.40 1.29 
Tracking (e.g., assessing) patients while not at your clinic (i.e., remotely) 2.12 1.21 
Liability issues (e.g., malpractice) 2.78 1.06 
Improving the accuracy of the assessments 3.57 1.06 
Getting results of the assessments more quickly 3.12 1.05 
Being able to access the results of an assessment remotely 2.66 1.38 
Increasing the frequency of assessments 2.42 1.17 
Range 1 (not at all), 2 (a little), 3 (somewhat), 4(very much), and 5 (Extremely). 
 
 
